Delivery Order SPE2DB20D1050-SPE2DB24FH50H
Award Date 2/8/24
Potential Completion Date 2/9/24
Potential Value $3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,111.15 to AmerisourceBergen Drug Corporation, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the supply of Ondansetron HCL 4 mg tablets in 30-count packaging to support military treatment programs and facilities. This delivery order is issued under an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 awarded...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $11,377.22 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 8 mg Ondansetron HCL tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to provide...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,668.97 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to support the Department of...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,517.44 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of 4,563,534,937 units of Ondansetron HCL 8 mg tablets, with a completion date of February 5, 2024. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $9,280.48, is for the delivery of Ondansetron HCL 8 mg tablets and has a performance period through March 27, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $10,834.11 firm fixed price delivery order contract to supply 4,564,205 units of 4 mg Ondansetron HCL tablets. The contract has an ultimate completion date of April 9, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and the parent company Cencora, Inc. conducts business as Amerisourcebergen. This delivery order is part of a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The contract, valued at $1,143.66, is for the supply of 8 mg Ondansetron HCl tablets over a period ending on February 6, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a wholly owned subsidiary of the parent company Cencora, Inc. The contract, valued at $4,248.11, is for the delivery of 500 units of 4 mg ondansetron hydrochloride tablets. AmerisourceBergen Drug Corp is the prime contractor and this award is not associated with any set-aside designations. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,686.75 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,563,557,459 units of Ondansetron ODT 8 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999.00, which runs through November 2026. The contract is for the provision of a comprehensive range of...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $15,076.86 contract is for the supply of Ondansetron ODT 4 mg tablets, with a period of performance through January 26, 2024. This delivery order is likely part of a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA to...